Signature Equity Partners’s Concentrix CNXC Stock Holding History

Signature Equity Partners’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-651	Closed	-$27.1K	–	1563
2025 Q4	$27.1K	Buy	+651	New	+$26.4K	0.02%	561

Other funds holding CNXC

GBL

Groupe Bruxelles Lambert Brussels, Belgium $62.2M AUM 57.6% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Signature Equity Partners's CNXC Position: Q1 2026 in Review

Signature Equity Partners sold out of Concentrix (CNXC) in Q1 2026, closing a stake of 651 shares — an estimated $27.1K sold.

Signature Equity Partners first reported a position in CNXC in Q4 2025 and held it in 1 quarter. The position peaked at $27.1K in Q4 2025. 304 funds tracked by Wall St. Rank hold CNXC as of Q1 2026.

Signature Equity Partners reported no remaining Concentrix position as of Q1 2026 after selling out during the quarter.
Signature Equity Partners sold 651 Concentrix shares in Q1 2026, an estimated $27.1K.
Signature Equity Partners first reported a position in Concentrix in Q4 2025 and held it in 1 quarter.
Signature Equity Partners's Concentrix position peaked at $27.1K in Q4 2025.
304 funds tracked by Wall St. Rank held Concentrix as of Q1 2026.

Based on Signature Equity Partners's 13F filing for Q1 2026, filed 13 May 2026.